Mylan Sues Celgene for Blocking Access to Generics
Generics giant Mylan is suing Celgene Corp, accusing Celgene of maintaining unlawful monopolies over Revlimid and Thalomid, by blocking generic versions from the market.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Revlimid